Details

Autor(en) / Beteiligte

• Christie, Athalia
• Gay, Andrea
• Durrheim, David N
• Bashour, Hyam
• Andrus, Jon Kim
• de Quadros, Ciro A
• Heymann, David
• Fine, Paul E
• Griffiths, Ulla K
• Hall, Andew J

Titel

Measles eradication/Authors' reply

Ist Teil von

• The Lancet (British edition), 2011-03, Vol.377 (9768), p.807

Ort / Verlag

London: Elsevier Limited

Erscheinungsjahr

2011

Quelle

Elsevier ScienceDirect Journals

Beschreibungen/Notizen

• Between 2000 and 2008, about 686 million children received measles vaccine through campaigns and routine coverage rose from 72% to 83%.3 As a result, global measles deaths declined by 78%.3 Measles campaigns also provide a rapid and equitable means of reaching children across all wealth quintiles with multiple interventions.4 Since 2001, integrated campaigns have delivered more than 41 million insecticidetreated nets, 94 million deworming tablets, 127 million polio vaccines, and 213 million doses of vitamin A (Measles Initiative, un published data). Attaining high cover age of measles im munisation worldwide represents one of the most effective propoor strategies available.2 Between 2000 and 2008, an estimated 4.3 million additional child deaths were averted as a result of accelerated measles control efforts, including increases in routine measles immun isation coverage and administration of more than 600 million doses of measles vaccine in mass vaccination campaigns. Routine vaccination coverage is high in the region of the Americas, and that has certainly contributed not only to the inter ruption of wild poliovirus transmission, but also to the interruption of indigenous transmission of measles virus in 2002, hence achieving the elimination of measles in the region.